SEC Filing Details
Document Details
Form
Filing Date
Oct 18, 2016
Document Date
Oct 18, 2016
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
CRISPR Therapeutics
Issuer
CRISPR Therapeutics AG
Filer
Lundberg Sven Ante